trending Market Intelligence /marketintelligence/en/news-insights/trending/bmnlkwkabvuiyhihdmbtnw2 content
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

Thank you for your interest in S&P Global Market Intelligence! We noticed you've identified yourself as a student. Through existing partnerships with academic institutions around the globe, it's likely you already have access to our resources. Please contact your professors, library, or administrative staff to receive your student login.

At this time we are unable to offer free trials or product demonstrations directly to students. If you discover that our solutions are not available to you, we encourage you to advocate at your university for a best-in-class learning experience that will help you long after you've completed your degree. We apologize for any inconvenience this may cause.

In This List

GSK CFO to retire in 2019; Sangamo Therapeutics' chief business officer resigns

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry

Segment

IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help

The Market Intelligence Platform


GSK CFO to retire in 2019; Sangamo Therapeutics' chief business officer resigns

S&P Global Market Intelligence presents a weekly rundown of recent executive changes at pharmaceutical, biotech and life sciences companies.

* Simon Dingemans is retiring as GlaxoSmithKline PLC's CFO and board member in May 2019.

* Sangamo Therapeutics Inc. said its senior vice president and chief business officer Curt Herberts III will resign June 1 to pursue an opportunity elsewhere. Concurrently, the company promoted Michael Holmes to senior vice president and chief technology officer.

* Flexion Therapeutics Inc. named David Arkowitz its CFO, replacing Frederick Driscoll, who retired in 2017 but continued with the company as a financial adviser.

* OraSure Technologies Inc. appointed Roberto Cuca to replace Ronald Spair as CFO, effective June 8.

* NeoGenomics Inc. appointed Stephanie Bywater to be the company's chief compliance officer, replacing Steven Jones. Jones, who has been an officer and director at NeoGenomics for 15 years, will continue as executive vice president and a member of the board.

* Syneos Health Inc. permanently appointed Jason Meggs to the position of CFO. Meggs had been the executive vice president and interim CFO of the company since Feb. 21.

* BioDelivery Sciences International Inc. appointed Herm Cukier CEO and a director.

* Versartis Inc. terminated 13 employees, including Chief Medical Officer Robert Gut, as part of plans to cut costs and restructure.

* Menlo Therapeutics Inc. appointed Paul Kwon its chief scientific officer. Kwon was Menlo's chief medical officer prior to the appointment. That position will now be held by Mary Spellman, the company's senior vice president of clinical development.

* Evolus Inc. appointed former Allergan PLC executive David Moatazedi as its president and CEO, replacing Murthy Simhambhatla. The company said Simhambhatla stepped down to pursue other options and was supportive of the transition.

* Proteostasis Therapeutics Inc. said Helen Boudreau resigned as CFO and treasurer of the company to pursue an opportunity elsewhere. She will retain her roles until June 1.

* Nemus Bioscience Inc. said Elizabeth Berecz will be stepping down as CFO, effective May 25. Doug Cesario will be taking over as the new CFO from May 26.

* OncoSec Medical Inc. said it combined the roles of CEO and president May 2, with Daniel O'Connor serving as both.

* Pharnext S.A. appointed Amit Kohli COO.

* TRACON Pharmaceuticals Inc. said Patricia Bitar resigned as CFO, effective June 15.

* Marina Biotech Inc. said Joseph Ramelli resigned as its CEO. Vuong Trieu will take over as interim CEO.

* Sernova Corp. appointed Sean Hodgins its CFO, with immediate effect. Hodgins succeeds Scott Langille.

* Adverum Biotechnologies Inc. said Amber Salzman stepped down as president, CEO and director. The company has appointed Leone Patterson as interim president and CEO. Adverum also announced the resignation of Athena Countouriotis as chief medical officer, to be replaced by Linda Neuman on an interim basis.

* Oncodesign SA said Laurent Gonthiez stepped down as the CFO of the company. Arnaud Lafforgue was appointed to fill the vacated CFO role.

* CytRx Corp. appointed Eric Curtis as the company's president and COO.

* Gemphire Therapeutics Inc. said it appointed interim President and CEO Steven Gullans to those positions permanently.